TNNT2 and heart failure: Accordingly, some clinical studies specifically evaluating the cost-benefit of a screening in the general population should be promoted in order to identify individuals at high-risk of progression toward symptomatic heart failure, by using the hs-TnI and hs-cTnT methods.